More on GH
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $161.41 |
|
|||
| Open | $166.11 | ||||
| 52 Wk High | $5.84 | ||||
| 52 Wk Low | $5.49 | ||||
| Day High | $166.69 | ||||
| Day Low | $160.25 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,038,111 | ||||
- Rothschild Redburn Starts Guardant Health (GH) at Buy
- Guardant Health (GH) call put ratio 1 call to 6.9 puts with a focus on September 150 and 160 puts
- Form 4 Guardant Health, Inc. For: Aug 26 Filed by: Eltoukhy Helmy
- TD Cowen Reiterates Buy Rating on Guardant Health (GH), $245M Patent Judgment Risks Seen as Managable
- Form 4 Guardant Health, Inc. For: Aug 21 Filed by: Talasaz AmirAli
- Form 4 Guardant Health, Inc. For: Aug 21 Filed by: MIGNONE ROBERTO
- Guardant Health to appeal Delaware patent ruling by TwinStrand
- Guardant Health to Appeal Federal District Court Judgment
- Court awards TwinStrand $245.2M in Guardant Health patent case
- TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University of Washington More Than $245.2 Million in Damages, Accrued R
Entities mentioned with GH
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
